Zhenfeng Duan

Harvard University — United States

Medicine · Health Sciences

45h-index5.4kcitations181works4.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Sarcoma Diagnosis and Treatment(45), Cancer-related Molecular Pathways(34), RNA modifications and cancer(32), Bone Tumor Diagnosis and Treatments(29), Cancer-related molecular mechanisms research(18)

Publications181 total

Retraction Note: Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer
Molecular Cancer·2025· 1 citedOpen Access
CDK11 Mediates Autophagy to Promote Breast Cancer Cell Proliferation and Migration by Regulating BCL‐2
The FASEB Journal·2025
Mutational analysis of primary and advanced chordoma tissue using next‐generation sequencing
Cancer·2025· 3 citedOpen Access
Correction to: IAPP modulates cellular autophagy, apoptosis, and extracellular matrix metabolism in human intervertebral disc cells
Cell Death Discovery·2025Open Access
High-Throughput Drug Screening in Chondrosarcoma Cells Identifies Effective Antineoplastic Agents Independent of IDH Mutation
International Journal of Molecular Sciences·2024· 1 citedOpen Access
Advances in the molecular biology of the solitary fibrous tumor and potential impact on clinical applications
Cancer and Metastasis Reviews·2024· 16 citedOpen Access
Transcriptional regulation and therapeutic potential of cyclin-dependent kinase 9 (CDK9) in sarcoma
Biochemical Pharmacology·2024· 10 cited
Correction: Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143/HK2 axis in gallbladder cancer
Molecular Cancer·2024· 3 citedOpen Access
Therapeutic Perspectives for Inflammation and Senescence in Osteoarthritis Using Mesenchymal Stem Cells, Mesenchymal Stem Cell-Derived Extracellular Vesicles and Senolytic Agents
Cells·2023· 37 citedOpen Access
Supplementary Figure Legends from Programmed Cell Death Ligand 1 Expression in Osteosarcoma
2023Open Access
Data from Programmed Cell Death Ligand 1 Expression in Osteosarcoma
2023Open Access
Supplementary Figure 1 from Programmed Cell Death Ligand 1 Expression in Osteosarcoma
2023Open Access
Data from Programmed Cell Death Ligand 1 Expression in Osteosarcoma
2023Open Access
Supplementary Figure 1 from Programmed Cell Death Ligand 1 Expression in Osteosarcoma
2023Open Access
Data from Cyclin G–Associated Kinase Is Necessary for Osteosarcoma Cell Proliferation and Receptor Trafficking
2023Open Access
Supplementary Figure Legends from Programmed Cell Death Ligand 1 Expression in Osteosarcoma
2023Open Access
Supplementary Figure 1 from Cyclin G–Associated Kinase Is Necessary for Osteosarcoma Cell Proliferation and Receptor Trafficking
2023Open Access
Data from Cyclin G–Associated Kinase Is Necessary for Osteosarcoma Cell Proliferation and Receptor Trafficking
2023Open Access
Supplementary Figure 1 from Cyclin G–Associated Kinase Is Necessary for Osteosarcoma Cell Proliferation and Receptor Trafficking
2023Open Access
Data from Effects of Siltuximab on the IL-6–Induced Signaling Pathway in Ovarian Cancer
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Francis J. Hornicek(34), Henry J. Mankin(15), Edwin Choy(14), Dylan C. Dean(8), Jacson Shen(8), Yang Cao(7), Joseph H. Schwab(5), Rosemary Foster(4), Michael V. Seiden(4), Hashem B. El‐Serag(4), Nicole A. Seebacher(4), Yubing Zhou(4), Zujiang Yu(4), Quancheng Kan(4), David C. Harmon(4), Jennifer Mahoney(3), Pichaya Thanindratarn(3), Yan Gao(3), Andrew E. Rosenberg(3), Yong Feng(3)